T2 Biosystems Inc. [NASDAQ: TTOO] closed the trading session at $1.60 on 01/11/21. The day’s price range saw the stock hit a low of $1.45, while the highest price level was $1.64. The company report on January 12, 2021 that T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus.
Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced that its T2SARS-CoV-2™ Panel—a molecular diagnostic test that detects SARS-CoV-2, the virus responsible for COVID-19 infections—is capable of detecting the multiple variants of the SARS-CoV-2 virus most recently identified in the United Kingdom, South Africa, and the United States.
The stocks have a year to date performance of 29.03 percent and weekly performance of 20.30 percent. The stock has been moved at 20.30 percent over the last six months. The stock has performed 42.86 percent around the most recent 30 days and changed 16.79 percent over the most recent 3-months.
If compared to the average trading volume of 3.78M shares, TTOO reached to a volume of 9621356 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about T2 Biosystems Inc. [TTOO]:
BTIG Research have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 08, 2020. The new note on the price target was released on November 26, 2019, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.10, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 17.55. The Price to Book ratio for the last quarter was 13.33, with the Price to Cash per share for the same quarter was set at 0.28.
TTOO stock trade performance evaluation
T2 Biosystems Inc. [TTOO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.30. With this latest performance, TTOO shares gained by 42.86% in over the last four-week period, additionally plugging by 20.30% over the last 6 months – not to mention a rise of 35.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 74.47, with the RSI for the last a single of trading hit 79.74, and the three-weeks RSI is set at 69.39 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 1.2056, while it was recorded at 1.4440 for the last single week of trading, and 1.1858 for the last 200 days.
T2 Biosystems Inc. [TTOO]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -624.57 and a Gross Margin at -101.12. T2 Biosystems Inc.’s Net Margin is presently recorded at -707.93.
Additionally, TTOO Total Debt to Total Capital is recorded at 366.64, with Total Debt to Total Assets ending up at 164.14.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$390,768 per employee. Receivables Turnover for the company is 3.62 with a Total Asset Turnover recorded at a value of 0.18.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.60 and a Current Ratio set at 5.00.
Earnings per share (EPS) analysis for T2 Biosystems Inc. [TTOO] stock
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.29/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
T2 Biosystems Inc. [TTOO]: Insider Ownership positions
There are presently around $29 million, or 12.70% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 5,364,440, which is approximately 12.706% of the company’s market cap and around 0.10% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $6.97 million in TTOO stocks shares; and BLACKROCK INC., currently with $3.53 million in TTOO stock with ownership of nearly 34.567% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 34 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,058,876 shares. Additionally, 15 investors decreased positions by around 710,255 shares, while 16 investors held positions by with 13,461,567 shares. The mentioned changes placed institutional holdings at 18,230,698 shares, according to the latest SEC report filing. TTOO stock had 15 new institutional investments in for a total of 1,087,229 shares, while 7 institutional investors sold positions of 242,873 shares during the same period.